Stock 575 REGENT PACIFIC GROUP LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Company Regent Pacific Group Limited Hong Kong S.E.

Equities

575

KYG3042R1231

Pharmaceuticals

End-of-day quote Hong Kong S.E.
Other stock markets
 23:00:00 04/02/2024 GMT 		5-day change 1st Jan Change
0.47 HKD -.--% Intraday chart for Regent Pacific Group Limited -17.54% -24.19%
07-02 Regent Pacific Group's Unit Terminates Disposal MT
07-02 Qujing Black Gold Energy Co., Ltd. cancelled the acquisition of 25% stake in West China Coking & Gas Company Limited from Regent Pacific Group Limited. CI

Business Summary

Regent Pacific Group Ltd, formerly Endurance RP Ltd is an investment holding company principally engaged in biopharma and investment businesses. The Company operates its business through two segments. The Biopharma segment is engaged in the research, development, manufacture, marketing and sale of pharmaceutical products. The Corporate Investment segment is engaged in the investment in listed and unlisted corporate entities. The Company is also engaged in aging research and developing artificial intelligence (AI) models and tool products related to aging research. It offers aging and longevity clocks to the longevity clinics, preventative medicine organizations, health clubs, insurance companies, and aging research institutions.

Sales per Business

HKD in Million2022Weight2023Weight Delta
Biopharma
100.0 %
0 100.0 % 2 100.0 % +731.26%

Sales per region

HKD in Million2022Weight2023Weight Delta
Europe
83.5 %
0 31.4 % 2 83.5 % +2,108.65%
United States
12.0 %
-- 0 12.0 % -
Asia Pacific
4.5 %
-- 0 4.5 % -

Managers

Managers TitleAgeSince
Jamie Gibson CEO
 Chief Executive Officer 58 31/03/96
Jim Mellon FOU
 Founder 68 31/12/89
Yui Fui Wong DFI
 Director of Finance/CFO 49 31/12/10
Paul Eric Jones CIO
 Chief Investment Officer 59 31/03/11
Michael Wyllie CTO
 Chief Tech/Sci/R&D Officer 73 -
Jayne Allison Sutcliffe BRD
 Director/Board Member 60 31/12/89
David Samuel Church LAW
 General Counsel 49 31/08/08
Mei Yan Lui SEC
 Corporate Secretary 49 31/05/21

Members of the board

Members of the board TitleAgeSince
Jim Mellon FOU
 Founder 68 31/12/89
Jamie Gibson CEO
 Chief Executive Officer 58 31/03/96
Stawell Searle BRD
 Director/Board Member 80 30/09/01
Jayne Allison Sutcliffe BRD
 Director/Board Member 60 31/12/89
Wan Tsun Chan BRD
 Director/Board Member 45 20/04/23
Ihsan Al Chalabi BRD
 Director/Board Member 54 14/08/23

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 228,392,286 91,878,722 ( 40.23 %) 0 40.23 %

Holdings

NameEquities%Valuation
CONDOR GOLD PLC
0.25%
 499,000 0.25% 174,715 $
TRINITY EXPLORATION & PRODUCTION PLC
0.11%
 41,000 0.11% 24,012 $

Company contact information

Regent Pacific Group Ltd.

Henley Building 5 Queen's Road Central

, Hong Kong

+852 2514 6111

http://www.endurancerp.com
address Regent Pacific Group Limited(575)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Other Pharmaceuticals

Sales per Business

Sales per region

Sector Other Pharmaceuticals

1st Jan change Capi.
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+54.07% 809B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+38.59% 621B
JOHNSON & JOHNSON Stock Johnson & Johnson
-7.05% 351B
MERCK & CO., INC. Stock Merck & Co., Inc.
+15.44% 319B
ABBVIE INC. Stock AbbVie Inc.
+5.72% 289B
ASTRAZENECA PLC Stock AstraZeneca PLC
+13.40% 238B
ROCHE HOLDING AG Stock Roche Holding AG
+0.61% 221B
NOVARTIS AG Stock Novartis AG
+13.24% 218B
AMGEN INC. Stock Amgen Inc.
+7.42% 166B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. 575 Stock
  4. 575 Stock
  5. Company Regent Pacific Group Limited